Clinical Trials Browser

Phase 1/2 × Papillomavirus Infections × 1 year × Clear all

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

141 enrolled

Sexually Transmitted Diseases, Papillomavirus Infections

NCT04607850 2025-08-28

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

Phase 1/2 Completed

108 enrolled

Papillomavirus Infections

NCT05592626 2025-07-09

START-001

Phase 1/2 Recruiting

365 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Phase 1/2 Active not recruiting

38 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

Clinical Trials

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

START-001

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis